01 /What it is
Modified GRF 1-29 is a synthetic 29 amino acid GHRH analog with four amino acid substitutions that enhance enzymatic stability over native GHRH. It is the same molecule that the research peptide market also sells under the name CJC-1295 (no DAC).
02 /How it works
In growth hormone axis research, Modified GRF 1-29 is studied as a GHRH receptor agonist. Its mechanism is identical to CJC-1295 (no DAC); the two names refer to the same compound in the research peptide literature.
03 /What researchers explore it for
Researchers have explored Modified GRF 1-29 in growth hormone pulsatility research, in pairing research with ghrelin receptor agonists, and in stability comparison research with native GHRH.
04 /Safety and interactions
Modified GRF 1-29 is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: GHRH analogs. Identical to CJC-1295 (no DAC). The Apothify catalog lists both names for naming clarity and SEO coverage, but only ships product under the CJC-1295 (no DAC) entry to avoid double inventory.
Related peptides
CJC-1295 (no DAC) · Sermorelin · Ipamorelin